Drug Depot, Inc recalls
Drug Depot, Inc has 8 recalls on record with the FDA and USDA, the earliest in 2022 and the latest reported on 6 Apr 2022. The most frequent reason is sterility.
Total recalls8since 2022
Last 12 months0reported
Class I00% of total
Ongoing0latest 6 Apr 2022
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 8 100%Class III 0 0%
Why drug depot, inc is recalled
Product types
By year
All drug depot, inc recalls, newest first
8 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | (ca) Gonadorelin 2 MG/ML Injectable recalled by Drug Depot, Inc | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Anastrozole *GS* Oil 200MG/1MG/ML Injectable recalled | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate *GS* Oil 200 MG/ML Injectable recalled | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate *GS* 80 MG/ML Injectable recalled | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/Propionate *Ses* Oil 160MG/20MG/ML Injectable recalled | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/ Dhea *GS* 200/10MG/ML Injectable recalled | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Gonadorelin 2 MG/ML Injectable recalled by Drug Depot, Inc | Drug Depot, Inc | Sterility | Nationwide |
| Drug | CLASS II | Testosterone Cypionate/ Anastrozole *gs* Oil 200mg/0.5mg/ML recalled | Drug Depot, Inc | Sterility | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.